Reuters: Deals: Amgen, Astra to collaborate on several drugs

Reuters: Deals Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Amgen, Astra to collaborate on several drugs Apr 2nd 2012, 20:32 Mon Apr 2, 2012 4:32pm EDT (Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline. Under terms of the deal, Astra will make an upfront payment of $50 million to the world's largest biotechnology company and the companies will share costs and profits on the drugs for autoimmune and respiratory diseases. The collaboration will provide Amgen with additional resources to help advance its product portfolio and give Astra access to new medicines at a time when its own pipeline is relatively barren and it is facing competition from cheap generic versions of its big-selling antipsychotic drug Seroquel.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions